Skip to main content

Table 4 Baseline and follow-up measures a

From: Comparison of complementary and alternative medicine with conventional mind–body therapies for chronic back pain: protocol for the Mind–body Approaches to Pain (MAP) randomized controlled trial

Measures

Baseline

4 wk

8 wk

26 wk

52 wk

Baseline characteristics

     

   Patient characteristics (age, sex, education, race, ethnicity, marital status, income, work status, number of pain sites)

x

    

   Back pain (pain duration, interference with activities, days of pain in previous 6 months, previous spinal injections, whether pain radiates into leg below knee)

x

    

   Expectations for back pain improvement in general and as result of MBSR or CBT

x

    

Primary outcomes

     

   Back pain-related activity limitations in past week (modified RDQ)

x

x

x

x

x

   Bothersomeness of back pain in past week (0 to 10 scale)

x

x

x

x

x

Secondary outcomes

     

   Characteristic pain intensity (GCPS) (average of pain now, worst pain, average pain)

x

 

x

x

x

   Depression (PHQ-8)

x

 

x

x

x

   Anxiety (GAD-2)

x

 

x

x

x

   Medications used for back pain in past week

x

 

x

x

x

   Exercise in past week (back pain–specific and general)

x

 

x

x

x

   Global improvement (PGIC)

  

x

x

x

   Program’s impact on thoughts, feelings, reactions, activities (open-ended)

  

x

x

x

Potential mediators

     

   MBSR: mindfulness (FFMQ-SF), pain acceptance (CPAQ-8)

x

x

x

x

x

   CBT: pain beliefs and appraisals (PSEQ; SOPA 2-item control, disability and harm scales; PCS), pain coping strategies (CPCI activity pacing scale and 2-item relaxation scale)

x

x

x

x

x

Cost-effectiveness outcomes

     

   Quality of life (EQ-5D, SF-6D from the SF-12)

x

x

x

x

x

   Out-of-plan visits paid for by patients since previous follow-up interview

x

 

x

x

x

   Absenteeism, presenteeism (WPAI-CLBP)

x

 

x

x

x

   Costs paid by GHC (payer) for back-related utilization of services (visits, tests, prescriptions) and total costs (GHC members only) (from GHC electronic medical records for year prior to trial and for follow-up year)

 

Intervention-related information

     

   Class attendance (class records)

     

   Adverse experiences from classes or home practice

 

x

x

x

x

   New serious health problems since entering study

 

x

x

x

x

   Self-reported home practice

 

x

x

x

x

   Perceived helpfulness of classes and home practice

  

x

x

x

   Would recommend program to friends

  

x

x

x

  1. aCBT, Cognitive-behavioral therapy; CPAQ-8, 8-item Chronic Pain Acceptance Questionnaire; CPCI, Chronic Pain Coping Inventory; EQ-5D, European Quality of Life (EuroQol) instrument in 5 dimensions; FFMQ, Five Facet Mindfulness Questionnaire; GAD-2, 2-item Generalized Anxiety Disorder scale; GCPS, Graded Chronic Pain Scale; MBSR, Mindfulness-based stress reduction; PCS, Pain Catastrophizing Scale; PGIC, Patient Global Impression of Change scale; PHQ-8,8 item Patient Health Questionnaire; PSEQ, Patient Self-efficacy Questionnaire; RDQ, Roland Disability Questionnaire; SF-6D, Short Form Health Survey in 6 dimensions; SF-12, 12-item Short Form Health Survey; SOPA, Survey of Pain Attitudes; WPAI-CLBP, Work Productivity and Activity Impairment Questionnaire–Chronic Low Back Pain.